Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001680367-24-000040
Filing Date
2024-08-01
Accepted
2024-08-01 16:18:42
Documents
50
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sttk-20240630.htm   iXBRL 10-Q 712600
2 EX-31.1 sub-certxsection302xceoxq2.htm EX-31.1 17229
3 EX-31.2 sub-certxsection302xcfoxq2.htm EX-31.2 17169
4 EX-32.1 sub-certxsection906ofthesa.htm EX-32.1 9162
  Complete submission text file 0001680367-24-000040.txt   3949770

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sttk-20240630.xsd EX-101.SCH 24539
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sttk-20240630_cal.xml EX-101.CAL 36280
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sttk-20240630_def.xml EX-101.DEF 129372
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sttk-20240630_lab.xml EX-101.LAB 368218
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sttk-20240630_pre.xml EX-101.PRE 244064
52 EXTRACTED XBRL INSTANCE DOCUMENT sttk-20240630_htm.xml XML 447120
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39593 | Film No.: 241166999
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)